{"meshTagsMajor":["Gene Fusion"],"meshTags":["Adenocarcinoma","Choroid Neoplasms","Chromosomes, Human, Pair 2","DNA, Neoplasm","Female","Gene Fusion","Gene Rearrangement","Humans","Immunoenzyme Techniques","In Situ Hybridization, Fluorescence","Lung Neoplasms","Middle Aged","Prognosis","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor Protein-Tyrosine Kinases","Translocation, Genetic"],"meshMinor":["Adenocarcinoma","Choroid Neoplasms","Chromosomes, Human, Pair 2","DNA, Neoplasm","Female","Gene Rearrangement","Humans","Immunoenzyme Techniques","In Situ Hybridization, Fluorescence","Lung Neoplasms","Middle Aged","Prognosis","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor Protein-Tyrosine Kinases","Translocation, Genetic"],"genes":["ALK 2p23 fusion","ALK immunohistochemistry"],"organisms":["9606"],"publicationTypes":["Case Reports","Journal Article"],"title":"Choroidal metastases responsive to crizotinib therapy in a lung adenocarcinoma patient with ALK 2p23 fusion identified by ALK immunohistochemistry.","pubmedId":"24389446"}